Consider the dividend stocks that do not merely pay, but grow-like trees that stretch toward the sun, their branches bearing fruit each season. These are the guardians of capital, their dividends a testament to the fertile soil of their operations. Here are two such vessels, poised to carry their shareholders through the coming years.
So, why might this seemingly absurd partnership turn Lululemon’s fortunes around, and more importantly, should we be scrambling to scoop up the stock now?
Snap’s decline wasn’t just a solo act. Consumer discretionary stocks yawned their way through the day after September’s consumer sentiment numbers arrived like an unwelcome guest at a dinner party-lower than expected, but still somehow expected. Meanwhile, OpenAI, that AI darling who’s been winning the tech popularity contest since 2015, dropped a new app that smells suspiciously like a TikTok clone. I’ve seen this movie before, and it always ends with someone’s mom being a cameo in a video of a holographic avocado toast.
Between March 31 and June 30, New York’s Cullen Capital, ever the astute observer of financial theater, reduced its stake in the chemicals titan. The remaining 3.2 million shares, now worth $84.3 million, sit as a modest relic of former confidence. One might admire the precision of the transaction, though the arithmetic suggests a man selling his car before the bridge collapses.
Bloomberg, that sly purveyor of market whispers, spilled ink Monday night (and again Tuesday morning) about Verizon Communications allegedly courting EchoStar’s AWS-3 spectrum licenses. These digital real estate plots, valued at $9.8 billion on EchoStar’s books, are 5G’s favorite plaything-smooth, supple, and ripe for futurist fantasies.
Rivian Automotive (RIVN), that modern Icarus with its wings of lithium and carbon fiber, now trades at a valuation that might make a bankruptcy attorney blush. Its market cap has shriveled from $150 billion to $18 billion-a carcass picked clean by vultures in pinstripes. Yet here we find ourselves, staring at a company that builds electric trucks for customers who apparently prefer to order them rather than actually purchase them.
The acquisition, priced at $8 billion in cold, unyielding cash, has been ratified by both corporate hierarchies. Genmab’s high priests of profit declared this union would “meaningfully accelerate” their pilgrimage toward a “wholly owned model,” a phrase that drips with the irony of modern corporatist dogma. The deal’s consummation, expected in the first quarter of 2026, promises to “diversify revenue streams” and “drive sustained growth”-mantras chanted since time immemorial in the temple of shareholder value.
Consider the past twelve months: a $10,000 stake in BBAI would have swelled to $42,290, a sum that glimmers like a mirage in the desert of the S&P 500’s meager gains. Yet such growth is not the work of mere numbers. It is the product of contracts inked with government hands, of biometric systems that map the human face like constellations, and of a world intoxicated by the scent of artificial intelligence. But here lies the paradox-the same winds that lift a ship can capsize it. Revenue, once a river, now trickles; losses bloom like a noxious weed, swelling from $14.4 million to $228.6 million, a chasm that yawns beneath the surface.
Lockheed Martin, that eternal bird of steel reborn from the ashes of endless contracts, now finds itself perched in Summit’s portfolio like a gargoyle surveying a cathedral. The shares, purchased during the quarter ended June 30, 2025, represent 1.0295% of the fund’s 13F assets-a feather in the cap, but not the crown. The company’s own plumage shimmers with $71.84 billion in trailing revenue and a dividend yield of 2.66%, though its stock price slumps 19.7% below its 52-week zenith. A paradox: a firm both indispensable and vulnerable, like a knight clad in armor with a chink at the throat.
Another day, another stock that’s decided to moonwalk downward. Today’s victim? Etsy. Let’s dissect this disaster with the precision of a seasoned activist investor (read: someone who still hasn’t figured out dollar-cost averaging).